1
Benjamin Oshlack, John J Minogue, Mark Chasin: Controlled release oxycodone compositions. Euroceltique, Steinberg & Raskin, November 30, 1993: US05266331 (268 worldwide citation)

A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 ...


2
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Stabilized controlled release formulations having acrylic polymer coating. Euroceltique, Steinberg & Raskin, February 15, 1994: US05286493 (266 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of an acrylic polymer is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of the plasticized acrylic polymer and then curing the coated substrate at ...


3
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled-release formulations coated with aqueous dispersions of ethylcellulose. Euroceltique, Steinberg Raskin & Davidson, December 5, 1995: US05472712 (256 worldwide citation)

A stabilized solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic polymer is obtained by overcoating a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic ...


4
Richard Sackler, Paul Goldenheim, Robert Kaiko: Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level. Euroceltique, Steinberg Raskin & Davidson, December 26, 1995: US05478577 (250 worldwide citation)

Patients are treated with 24-hour oral sustained release opioid formulations which upon administration quickly release an effective portion of the opioid contained therein such that there is an initially more rapid opioid release so that the minimum effective analgesic concentration of the opioid ca ...


5
Benjamin Oshlack, James McGinity, Mark Chasin, Roland Bodmeier: Controlled release coatings derived from aqueous dispersions of zein. Euroceltique, Steinberg Raskin & Davidson, October 18, 1994: US05356467 (239 worldwide citation)

Stable aqueous dispersions of zein which may be used as controlled release coatings of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.


6
Benjamin Oshlack: Controlled release bases for pharmaceuticals. Euroceltique, Steinberg & Raskin, August 29, 1989: US04861598 (239 worldwide citation)

The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.


7
Gordon Elger, Stewart T Leslie, Sandra T A Malkowska, Ronald B Miller, Philip J Neale: Controlled release pharmaceutical composition. Euroceltique, Steinberg & Raskin, May 30, 1989: US04834985 (219 worldwide citation)

A solid, controlled release, pharmaceutical composition comprising an active ingredient incorporated in a matrix comprising a first substance selected from a water soluble polydextrose and a water soluble cyclodextrin and a second substance selected from a C.sub.12 -C.sub.36 fatty alcohol and a poly ...


8
Gordon A Elger, Stewart T Leslie, Sandra T A Malkowska, Ronald B Miller, Philip J Neale: Controlled release pharmaceutical composition. Euroceltique, Steinberg & Raskin, May 9, 1989: US04828836 (197 worldwide citation)

A solid, controlled release, pharmaceutical composition comprising an active ingredient incorporated in a controlled release matrix comprising a water soluble polydextrose.


9
Benjamin Oshlack: Controlled release bases for pharmaceuticals. Euroceltique, Steinberg & Raskin, November 13, 1990: US04970075 (196 worldwide citation)

The release of therapeutically active agents from controlled release bases is extended by using a combination of a higher aliphatic alcohol and an acrylic resin as the base material.


10
Robert S Goldie, Sandra T A Malkowska, Stewart T Leslie, Ronald B Miller: Controlled release hydromorphone composition. Euroceltique, Steinberg & Raskin, July 4, 1989: US04844909 (172 worldwide citation)

A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of hydromorphone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method at 100 rpm in 900 ml aqueous buffer (pH between ...



Click the thumbnails below to visualize the patent trend.